New Strategies for Volume Control in Patients with Diabetes Mellitus, a Narrative Review

New Strategies for Volume Control in Patients with Diabetes Mellitus, a Narrative Review

Sodium is reabsorbed all along the renal tubules. The positive impacts of sodium-glucose cotransporter-2 inhibitors (SGLT2i), angiotensin receptor neprilysin inhibitor (ARNI) and mineralocorticoid receptor antagonists (MRA) on hard renal and/or cardiac endpoints calls for the role of diuretics in ne...

Full description

Bibliographic Details
Main Authors:	Alexandre O. Gérard, Audrey Laurain, Antoine Sicard, Diane Merino, Atul Pathak, Milou-Daniel Drici, Guillaume Favre, Vincent L. M. Esnault
Format:	Article
Language:	English
Published:	MDPI AG 2022-07-01
Series:	Pharmaceutics
Subjects:	diuretics aldosterone breakthrough heart failure congestion kidney proteinuria
Online Access:	https://www.mdpi.com/1999-4923/14/8/1569

Similar Items

The Changing Role of Loop Diuretics in Heart Failure Management across the Last Century
by: Alberto Palazzuoli, et al.
Published: (2024-03-01)

Effects of Spironolactone in Combination with Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers in Patients with Proteinuria
by: Ha Yeon Kim, et al.
Published: (2014-12-01)

Diuretic treatment in chronic heart failure
by: Camelia C. DIACONU, et al.
Published: (2016-06-01)

Prevalence of an angiotensin-converting enzyme gene variant in dogs
by: D. B. Adin, et al.
Published: (2021-07-01)

Primary aldosteronism and pregnancy
by: V.I. Medved, et al.
Published: (2022-05-01)

Beneficial long-term effect of aldosterone antagonist added to a traditional blockade of the renin–angiotensin–aldosterone system among patients with obesity and proteinuria
by: Enrique Morales, et al.
Published: (2015-11-01)

Beneficial long-term effect of aldosterone antagonist added to a traditional blockade of the renin–angiotensin–aldosterone system among patients with obesity and proteinuria
by: Enrique Morales, et al.
Published: (2015-11-01)

Effects of Metolazone Administration on Congestion, Diuretic Response and Renal Function in Patients with Advanced Heart Failure
by: Alberto Palazzuoli, et al.
Published: (2021-09-01)

Renal Mechanisms of Diuretic Resistance in Congestive Heart Failure
by: Norbert Lameire
Published: (2023-01-01)

Prognosis of emergency room stabilization of decompensated congestive heart failure with high dose lasix
by: Mahboob Pouraghaei, et al.
Published: (2015-06-01)

Role of electrolyte concentrations and renin‐angiotensin‐aldosterone activation in the staging of canine heart disease
by: Darcy Adin, et al.
Published: (2020-01-01)

Cuantificación y tratamiento de la congestión en insuficiencia cardíaca: una visión clínica y fisiopatológica
by: Rafael de la Espriella, et al.
Published: (2022-03-01)

Renin-Angiotensin-Aldosterone System Activation and Diuretic Response in Ambulatory Patients With Heart FailurePlain-Language Summary
by: Jonathan G. Amatruda, et al.
Published: (2022-06-01)

Lupus nephropathy beyond immunosuppression: Searching for nephro and cardioprotection
by: Enrique Morales, et al.
Published: (2023-01-01)

The influence of renin angiotensin aldosterone system blockers on asymmetric dimethylarginine levels in patients with chronic glomerulonephritis
by: Heleniak Zbigniew, et al.
Published: (2016-12-01)

PHANTOM TUMOR OF THE LUNG IN PATIENT WITH PNEUMONIA
by: Mulic Mersudin, et al.
Published: (2019-05-01)

Timing of decongestion and its impact on acute heart failure prognosis
by: Aneta Kosiorek, et al.
Published: (2023-08-01)

Management of Decongestion in Acute Heart Failure: Time for a new approach?
by: Miftah Pramudyo
Published: (2023-05-01)

A second-generation artificial intelligence-based therapeutic regimen improves diuretic resistance in heart failure: Results of a feasibility open-labeled clinical trial
by: Ram Gelman, et al.
Published: (2023-05-01)

Clinical phenotypes according to diuretic combination in acute heart failure
by: Raquel López-Vilella, et al.
Published: (2023-09-01)

Pharmacokinetic and pharmacodynamic properties of orally administered torasemide in healthy cats
by: Marine Roche‐Catholy, et al.
Published: (2022-09-01)

Clinical efficacy of a benazepril and spironolactone combination in dogs with congestive heart failure due to myxomatous mitral valve disease: The BEnazepril Spironolactone STudy (BESST)
by: Melissa Coffman, et al.
Published: (2021-07-01)

Pathogenesis and Treatment of Refractory Oedema in Nephrotic Syndrome
by: Priyanka Jethwani, et al.
Published: (2021-08-01)

Diuretic dose is a strong prognostic factor in ambulatory patients awaiting heart transplantation
by: Guillaume Baudry, et al.
Published: (2023-10-01)

Evaluation of intra-abdominal pressure as an early marker of diuretic response in patients with cardiorenal syndrome
by: Silvia Crespo-AznÃ¡rez, et al.
Published: (2023-01-01)

Pleural effusion resembling a lung tumor: phantom tumor of the lung
by: Soorih Shaikh, et al.
Published: (2016-01-01)

In dogs with congestive heart failure, is torasemide superior to furosemide as a first line diuretic treatment?
by: Leo Packham
Published: (2020-11-01)

Possible Option for Treatment of Severe Congestive Heart Failure Under Mechanical Ventilation Using Tolvaptan via Nasogastric Tube: A Single-Center Analysis
by: Takeda Morihiko, et al.
Published: (2021-12-01)

Incidental Congestive Heart Failure in Patients With Aldosterone‐Producing Adenomas
by: Wei‐Chieh Huang, et al.
Published: (2019-12-01)

Multimodal Strategies for the Diagnosis and Management of Refractory Congestion. An Integrated Cardiorenal Approach
by: Diana Rodríguez-Espinosa, et al.
Published: (2022-07-01)

All diuretics used in the treatment of hypertension are not the same
by: Serkan Asil, et al.
Published: (2017-01-01)

Decongestive diuresis using combination intravenous loop diuretics plus chlorothiazide in type 1 acute cardiorenal syndrome and worsening acute kidney injury; a neglected paradigm in resource-poor settings
by: Macaulay Amechi Chukwukadibia Onuigbo
Published: (2020-05-01)

The Role of Sodium-Glucose Co-Transporter-2 Inhibitors on Diuretic Resistance in Heart Failure
by: Panagiotis Stachteas, et al.
Published: (2024-03-01)

Prognostic Impact of Induced Natriuresis in Acute Decompensated Heart Failure and Its Association with Intraabdominal Pressure and Other Congestion Markers: A Multimodal Approach to Congestion Assessment
by: Silvia Crespo-Aznarez, et al.
Published: (2024-02-01)

The Effect in Renal Function and Vascular Decongestion in Type 1 Cardiorenal Syndrome Treated with Two Strategies of Diuretics, a Pilot Randomized Trial
by: Jonathan S. Chávez-Iñiguez, et al.
Published: (2022-01-01)

Blood Pressure Control and Antihypertensive Treatment among Hemodialysis Patients—Retrospective Single Center Experience
by: Piotr Skonieczny, et al.
Published: (2021-06-01)

Stroke Outcome Related to Initial Volume Status and Diuretic Use
by: Christopher J. Renner, et al.
Published: (2022-12-01)

Urine sodium concentration after intravenous furosemide in dogs with acute congestive heart failure and correlation with treatment efficacy
by: Victoria Convey, et al.
Published: (2024-01-01)

Role of Early Assesment of Diuresis and Natriuresis in Detecting In-Hospital Diuretic Resistance in Acute Heart Failure
by: Belén García-Magallón, et al.
Published: (2022-05-01)

Exponential Models of Breakthrough Development of Industrial Systems for Achievement of Global Competitiveness
by: Tolstykh T.O., et al.
Published: (2019-01-01)